Skip to main content
. 2013 Mar 15;10(5):567–574. doi: 10.7150/ijms.5795

Figure 4.

Figure 4

Cumulative viral breakthrough rates in lamivudine (LAM)-treated patients who achieved HBV DNA negativity and those who did not. (-), maintaining HBV DNA positivity; (+), achieving HBV DNA negativity. HBV DNA negativity was unknown in 9 patients because of lack of data.